On-Demand Platelets Instead of Depending on Blood Donors
Platelet transfusions save many lives, but supply is scarce, as the only source are blood donations. In addition to shortages, the transfusions can be contaminated and cause expensive, life- threatening complications.
HemostOD manufactures platelets on demand from engineered stem cells. The startup’s technology allows all patients to receive platelet therapy at a much lower risk, leading to faster recovery and better clinical outcomes at a greatly reduced cost.